title: Should I continue an experimental drug?
authors.forename: Paul R
authors.initials: PR
authors.lastname: Helft
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017321:Clinical Trials, Phase I as Topic / Q000941:ethics*; D003657:Decision Making; D005260:Female; D006801:Humans; D008495:Medical Oncology / Q000941:ethics*; D009364:Neoplasm Recurrence, Local; D009382:Neoplasms, Unknown Primary / Q000188:drug therapy* / Q000473:pathology; D009944:Organoplatinum Compounds / Q000008:administration & dosage*; D035703:Therapies, Investigational / Q000941:ethics*
chemical_list: D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds